NeuBase Therapeutics NBSE
$ 0.38
-1.56%
Quarterly report 2023-Q3
added 11-09-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Dietrich Stephan |
Employees in the company |
15 |
Shares |
32.5 M |
Market Cap[1] |
$ 12.3 M |
EBITDA (LTM) |
$ -14.6 M |
P/E (LTM) |
-0.23 |
P/S (LTM) |
-38.13 |
EPS (LTM) |
-2.95 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.